These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33797977)
1. Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling. Byrne CE; Decombe JB; Bingham GC; Remont J; Miller LG; Khalif L; King CT; Hamel K; Bunnell BA; Burow ME; Martin EC Tissue Eng Part A; 2021 Apr; 27(7-8):500-511. PubMed ID: 33797977 [TBL] [Abstract][Full Text] [Related]
2. Distinct phenotypes of cancer cells on tissue matrix gel. Ruud KF; Hiscox WC; Yu I; Chen RK; Li W Breast Cancer Res; 2020 Jul; 22(1):82. PubMed ID: 32736579 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer cells interact with tumor-derived extracellular matrix in a molecular subtype-specific manner. Tan Q; Xu L; Zhang J; Ning L; Jiang Y; He T; Luo J; Chen J; Lv Q; Yang X; Xie H Biomater Adv; 2023 Mar; 146():213301. PubMed ID: 36709629 [TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix, Rac1 signaling, and estrogen-induced proliferation in MCF-7 breast cancer cells. Xie JW; Haslam SZ Breast Cancer Res Treat; 2008 Jul; 110(2):257-68. PubMed ID: 17851761 [TBL] [Abstract][Full Text] [Related]
5. Laminin I mediates resistance to lapatinib in HER2-positive brain metastatic breast cancer cells in vitro. Gurung SK; Shevde LA; Rao SS Biochem Biophys Res Commun; 2024 Aug; 720():150142. PubMed ID: 38788545 [TBL] [Abstract][Full Text] [Related]
6. Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis. Conner SJ; Borges HB; Guarin JR; Gerton TJ; Yui A; Salhany KJ; Mensah DN; Hamilton GA; Le GH; Lew KC; Zhang C; Oudin MJ Cancer Res; 2024 Sep; 84(17):2761-2775. PubMed ID: 38900938 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer cells alter the dynamics of stromal fibronectin-collagen interactions. Wang K; Wu F; Seo BR; Fischbach C; Chen W; Hsu L; Gourdon D Matrix Biol; 2017 Jul; 60-61():86-95. PubMed ID: 27503584 [TBL] [Abstract][Full Text] [Related]
8. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
9. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices. Senthebane DA; Jonker T; Rowe A; Thomford NE; Munro D; Dandara C; Wonkam A; Govender D; Calder B; Soares NC; Blackburn JM; Parker MI; Dzobo K Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241395 [TBL] [Abstract][Full Text] [Related]
10. Dynamic interactions between the extracellular matrix and estrogen activity in progression of ER+ breast cancer. Jallow F; O'Leary KA; Rugowski DE; Guerrero JF; Ponik SM; Schuler LA Oncogene; 2019 Oct; 38(43):6913-6925. PubMed ID: 31406251 [TBL] [Abstract][Full Text] [Related]
11. ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer. Kyriakopoulou K; Riti E; Piperigkou Z; Koutroumanou Sarri K; Bassiony H; Franchi M; Karamanos NK Cells; 2020 Oct; 9(10):. PubMed ID: 33050027 [TBL] [Abstract][Full Text] [Related]
12. Laminin inhibits estrogen action in human breast cancer cells. Woodward TL; Lu H; Haslam SZ Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267 [TBL] [Abstract][Full Text] [Related]
13. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling. Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B Front Immunol; 2022; 13():859581. PubMed ID: 35795662 [TBL] [Abstract][Full Text] [Related]
14. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer. Zheng HM; Chen C; Wu XH; Chen J; Sun S; Sun JZ; Wang MW; Sun SR Tumour Biol; 2016 Feb; 37(2):2509-18. PubMed ID: 26385773 [TBL] [Abstract][Full Text] [Related]
15. Collagen I Fibrous Substrates Modulate the Proliferation and Secretome of Estrogen Receptor-Positive Breast Tumor Cells in a Hormone-Restricted Microenvironment. Reyes-Ramos AM; Álvarez-García YR; Solodin N; Almodovar J; Alarid ET; Torres-Garcia W; Domenech M ACS Biomater Sci Eng; 2021 Jun; 7(6):2430-2443. PubMed ID: 33688723 [TBL] [Abstract][Full Text] [Related]
16. Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns. Nolan J; Mahdi AF; Dunne CP; Kiely PA Gene; 2020 Nov; 761():145024. PubMed ID: 32755659 [TBL] [Abstract][Full Text] [Related]
17. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment. Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405 [TBL] [Abstract][Full Text] [Related]
18. Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling. Hamel KM; King CT; Cavalier MB; Liimatta KQ; Rozanski GL; King TA; Lam M; Bingham GC; Byrne CE; Xing D; Collins-Burow BM; Burow ME; Belgodere JA; Bratton MR; Bunnell BA; Martin EC Stem Cells Dev; 2022 Oct; 31(19-20):604-620. PubMed ID: 35579936 [TBL] [Abstract][Full Text] [Related]
19. Modulation of human iPSC-derived hepatocyte phenotype via extracellular matrix microarrays. Monckton CP; Brougham-Cook A; Underhill GH; Khetani SR Acta Biomater; 2022 Nov; 153():216-230. PubMed ID: 36115650 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Matrix-Bound FGF2 Mediates Estrogen Receptor Signaling and Therapeutic Response in Breast Cancer. DiGiacomo JW; Godet I; Trautmann-Rodriguez M; Gilkes DM Mol Cancer Res; 2021 Jan; 19(1):136-149. PubMed ID: 33033110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]